PVLA
NASDAQ · Biotechnology
Palvella Therapeutics Inc
$157.77
+2.84 (+1.83%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-66.5% upside
Low Target
$42.56
Average Target
$52.81
High Target
$76.13
Current Price
$157.77
Current
$157.77
$157.77
Target
$52.81
$52.81
$42.56
$52.81 avg
$76.13
Scenario Analysis
Bear Case
$42.56
-73.0%
Low target
Base Case
$52.81
-66.5%
Avg target
Bull Case
$76.13
+-51.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$161.38
-2.2% from high
52-Week Low
$37.33
+322.6% from low
Target vs 52W High
$52.81
-67.3% vs high
Next Earnings Report
Aug 13, 2026
3d
until earnings
EPS Est: $-1.18
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |